Turning the tide of early cancer detection
Next-generation liquid biopsy technologies that detect fragments of circulating cell-free tumor DNA could be a game-changer in early cancer detection.
Next-generation liquid biopsy technologies that detect fragments of circulating cell-free tumor DNA could be a game-changer in early cancer detection.
A longitudinal multiomic dataset was assembled to characterize the immune landscape in myocardial infarction and chronic coronary syndromes. Multiomics factor analysis (MOFA) revealed immune signatures that associate with disease stage or treatment outcomes. This work opens new directions for future mechanistic and clinical studies on coronary artery disease and myocardial infarction.